Generative AI-Assisted Clinical Decision Support for Medical Intensive Care Unit Physicians
Evaluation of the Feasibility and Effectiveness of Generative AI-Assisted Multidisciplinary Decision Support in Medical Intensive Care: A Pilot Randomized Controlled Trial
1 other identifier
interventional
15
1 country
1
Brief Summary
This pilot study evaluated the feasibility and usefulness of generative artificial intelligence (AI) as a clinical decision-support tool for physicians working in a medical intensive care unit. Participating physicians were assigned by work period to either use a generative AI system in addition to usual clinical information resources or to use usual resources without generative AI. The assigned condition was then switched so that participants experienced both approaches. During the AI-assisted periods, physicians used de-identified clinical information and considered the AI-generated responses as reference information. All final clinical decisions remained the responsibility of the treating physicians. The study assessed acceptability, usability, satisfaction, perceived decision support, workload, confidence, and learning experience through repeated questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
CompletedFirst Submitted
Initial submission to the registry
July 12, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedJuly 21, 2026
July 1, 2026
6 months
July 12, 2026
July 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Daily Physician Satisfaction Score
The score of 10 questionnaire items assessing physicians' satisfaction with their daily clinical work, modified from Shore and Franks (1986) and Suchman et al. (1993). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). Negatively worded items were reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating greater satisfaction.
At the end of each working day during the one-month medical intensive care unit rotation
Daily Clinical Decision-Making Score
The score of 6 questionnaire items assessing satisfaction with the clinical decision-making process, perceived decision difficulty, clarity of the preferred treatment, availability of relevant information, and identification of factors affecting the decision. Items were modified from Gedney (1994) and Dolan (1999) and rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). Negatively worded items were reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating a more favorable decision-making experience.
At the end of each working day during the one-month medical intensive care unit rotation
Perceived Quality Score for ChatGPT
The score of 8 questionnaire items assessing the perceived information quality, system quality, and service quality of ChatGPT, modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The negatively worded response-time item was reverse-scored. The mean score ranges from -2 to +2, with higher scores indicating better perceived quality.
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
Generative AI Usability Score
The score of 3 questionnaire items assessing ease of use, ease of learning, and clarity of interaction with Generative AI (ChatGPT), modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The mean score ranges from -2 to +2, with higher scores indicating greater usability.
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
Satisfaction Score for Generative AI Use
The score of 6 questionnaire items assessing the perceived usefulness, productivity, effectiveness, overall satisfaction, appropriateness, and intention to reuse Generative AI (ChatGPT), modified from Pillong et al. (2025). Each item was rated on a 5-point Likert scale from -2 (strongly disagree) to +2 (strongly agree). The mean score ranges from -2 to +2, with higher scores indicating greater satisfaction.
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
Other Outcomes (8)
Confidence
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
Perceived Acquisition of New Knowledge or Clinical Insight
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
Application of Generative AI-Derived Knowledge to Other Clinical Situations
At the end of the one-month medical intensive care unit rotation, after completion of both crossover periods
- +5 more other outcomes
Study Arms (2)
ChatGPT-Assisted Condition First, Then Control Condition
EXPERIMENTALPhysician clusters used ChatGPT-assisted clinical decision support during the first approximately two weeks of their one-month medical intensive care unit rotation. They then crossed over to the control condition and used usual clinical information resources without generative AI for the remainder of the rotation.
Control Condition First, Then ChatGPT-Assisted Condition
EXPERIMENTALPhysician clusters used usual clinical information resources without generative AI during the first approximately two weeks of their one-month medical intensive care unit rotation. They then crossed over to the ChatGPT-assisted clinical decision-support condition for the remainder of the rotation.
Interventions
During the assigned period, physicians were encouraged to use ChatGPT (OpenAI) as a generative AI-based reference tool to support clinical information review and decision-making.
During the control period, physicians used usual clinical information resources, including discussions with other clinicians, multidisciplinary rounds, specialty consultations, textbooks, clinical practice guidelines, PubMed, and established clinical reference services. No generative AI tool was used for clinical decision support during this period.
Eligibility Criteria
You may qualify if:
- Age 19 years or older.
- Physicians, including residents, fellows, and attending physicians, working in the medical intensive care unit at Seoul National University Hospital.
- Scheduled to work as a primary treating physician for at least 5 days during a planned observation period.
- Able and willing to provide written informed consent.
You may not qualify if:
- Did not provide written informed consent.
- Withdrew consent from study participation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Hospital
Seoul, Seoul, 03080, South Korea
Study Officials
- PRINCIPAL INVESTIGATOR
Minju Han, M.D.
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 12, 2026
First Posted
July 16, 2026
Study Start
December 1, 2025
Primary Completion
May 31, 2026
Study Completion
May 31, 2026
Last Updated
July 21, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because of the small sample size, the limited number of physicians working in the study setting, and the potential risk of re-identification even after removal of direct identifiers. External sharing of individual-level data was not included in the participant consent or institutional review board-approved data management plan.